Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -7.66% vs 45.69% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -30.09% vs 287.99% in Mar 2024
Interest
No Interest in the last few periods;
Profit After Tax
YoY Growth in year ended Mar 2025 is -14.16% vs 301.36% in Mar 2024
Compare Profit and Loss Results of Amwill Health
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
40.00
83.00
-43.00
-51.81%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
40.00
83.00
-43.00
-51.81%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
0.00
38.00
-38.00
-100.00%
Power & Fuel Cost
0.00
6.00
-6.00
-100.00%
Employee Cost
7.00
11.00
-4.00
-36.36%
Operating Expenses
11.00
6.00
5.00
83.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
7.00
4.00
3.00
75.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
3.00
-3.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
28.00
71.00
-43.00
-60.56%
Operating Profit (PBDIT) excl Other Income
11.00
11.00
0.00
0.00%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
12.00
13.00
-1.00
-7.69%
Interest
0.00
6.00
-6.00
-100.00%
Profit before Depriciation and Tax
12.00
6.00
6.00
100.00%
Depreciation
0.00
6.00
-6.00
-100.00%
Profit Before Taxation & Exceptional Items
11.00
0.00
11.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
11.00
0.00
11.00
0%
Provision for Tax
1.00
0.00
1.00
0%
Profit After Tax
10.00
0.00
10.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
17.00
46.00
-29.00
-63.04%
Profit Available for appropriations
27.00
46.00
-19.00
-41.30%
Appropriations
27.00
46.00
-19.00
-41.30%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
6.63
0.2
6.43
3,215.00%
Profit And Loss - Net Sales
Net Sales 40.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.66% vs 45.69% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.65 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -30.09% vs 287.99% in Mar 2024
Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025Figures in Cr
No Interest in the last few periods;
Profit And Loss - Profit After Tax
Profit After Tax 10.73 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -14.16% vs 301.36% in Mar 2024






